GGrantIndex
Sort

15,842 grants matching pancreatic cancer

SURGICAL STUDIES OF PANCREATIC STEM CELLS

$140,086
Johns Hopkins University · R01 · FY2000 · DK

Community Outreach Core

$139,935
Fern Jureidini Webb · University Of Florida · U54 · FY2024 · CA

Novel Gene MGC10471 in Pancreatic Cancer

$139,880
University Of The District Of Columbia · S06 · FY2004 · GM

Nanoparticles Targeting Pancreatic Cancer

$139,840
Dennis E Hallahan · Washington University · R21 · FY2009 · CA

Cell Culture and Tissue Morphology Core

$139,792
Bassem R Haddad · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA

Career Development Program

$139,758
Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2017 · CA

BIOBANK CORE

$139,703
Sarah P Thayer · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA

Project 1: Mutation-specific vulnerabilities for KRAS-targeted therapy

$139,601
Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA

Elucidating KRAS-specific vulnerabilities in pancreatic cancer

$139,563
Mandar Deepak Muzumdar · Yale University · K08 · FY2017 · CA

Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection

$139,507
Katharina Schlacher · University Of Tx Md Anderson Can Ctr · K22 · FY2014 · CA

Gemcitabine-Radiation for Advanced Pancreatic Cancer

$139,473
Theodore S Lawrence · University Of Michigan At Ann Arbor · R01 · FY2009 · CA

Selective Inhibition of HDAC6 in Cancer Therapy

$139,320
James E Bradner · Dana-Farber Cancer Inst · K08 · FY2011 · CA

Selective Inhibition of HDAC6 in Cancer Therapy

$139,320
James E Bradner · Dana-Farber Cancer Inst · K08 · FY2010 · CA

Selective Inhibition of HDAC6 in Cancer Therapy

$139,320
James E Bradner · Dana-Farber Cancer Inst · K08 · FY2009 · CA

Selective Inhibition of HDAC6 in Cancer Therapy

$139,320
James E Bradner · Dana-Farber Cancer Inst · K08 · FY2012 · CA

Selective Inhibition of HDAC6 in Cancer Therapy

$139,240
James E Bradner · Dana-Farber Cancer Inst · K08 · FY2008 · CA

Developmental Research Program

$139,135
Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2015 · CA

The crosstalk between obesity-induced fatty liver and liver metastasis

$139,125
Changyu Zhu · Sloan-Kettering Inst Can Research · K99 · FY2024 · CA

Role of microRNAs in genetic mouse models of pancreatic cancer

$139,113
Murray Korc · Dartmouth College · R21 · FY2010 · CA

Core 2: Biospecimen/Pathology Core

$139,011
Robert A Anders · Johns Hopkins University · P50 · FY2018 · CA

Development of Novel Markers for Melanoma Progression

$138,908
Byungwoo Ryu · Nevada Cancer Institute · K01 · FY2008 · CA

Breaking the Obesity-Cancer Link: New Targets and Strategies

$138,889
Stephen D Hursting · Univ Of North Carolina Chapel Hill · R35 · FY2019 · CA

Project 2

$138,776
Mustafa Raoof · Beckman Research Institute/City Of Hope · U54 · FY2024 · CA

IsoSpark single cell proteomic and transcriptomic system for Keck Microarray Shared Resource (KMSR)

$138,700
Guilin Wang · Yale University · S10 · FY2023 · OD

Cancer Epigenetics Training Program

$138,682
Feng-Chun Yang · University Of Miami School Of Medicine · T32 · FY2018 · CA